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Objectives: To evaluate the effect of interruption in radiotherapy due to machine
failure in patients and medical institutions using machine failure risk analysis
(MFRA).
Material and methods: The risk of machine failure during treatment is assigned to
three scores (biological effect, B; occurrence, O; and cost of labor and repair parts,
C) for each type of machine failure. The biological patient risk (BPR) and the eco-
nomic institution risk (EIR) are calculated as the product of B and O (BO) and C
and O (CO), respectively. The MFRA is performed in two linear accelerators (li-
nacs).
Result: The multileaf collimator (MLC) fault has the highest BPR and second highest
EIR. In particular, TrueBeam has a higher BPR and EIR for MLC failures. The total
EIR in TrueBeam was significantly higher than that in Clinac iX. The minor interlock
had the second highest BPR, whereas a smaller EIR. Meanwhile, the EIR for the
LaserGuard fault was the highest, and that for the monitor chamber fault was the
second highest. These machine failures occurred in TrueBeam. The BPR and EIR
should be evaluated for each linac. Further, the sensitivity of the BPR, it decreased
with higher T1=2 and α/β values. No relative difference is observed in the BPR for
each machine failure when T1=2 and α/β were varied.
Conclusion: The risk faced by patients and institutions in machine failure may be
reduced using MFRA.
Advances in knowledge: For clinical radiotherapy, interruption can occur from
unscheduled downtime with machine failures. Interruption causes sublethal damage
repair. The current study evaluated the effect of interruption in radiotherapy owing
to machine failure on patients and medical institutions using a new method, that is,
machine failure risk analysis.
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1 | INTRODUCTION
A linear accelerator (linac) that facilitates the treatment of cancer
comprises complex hardware and software. Development of the
linac has progressed steadily, and the reliability and consistency of
its operations have improved remarkably. However, linacs still occa-
sionally suffer occasionally from system dysfunction and failure.
Component dysfunction or failure calls for service engineering and
immediate on-site repair, resulting in the disruption of clinical ser-
vices and unscheduled machine downtime (DT) 1,2. This presents a
strain on the patients and involves a cost for the institution. Linac
interlocks prevent grave failures by ensuring that the operation of
the system is discontinued when the operating parameters exceed
the specified limits of the system. However, such interlocks can also
cause DT, thereby affecting clinical operations.
Sublethal damage repair (SLDR) is induced in patients for several
minutes or hours after irradiation for patients, and it causes
decreased cell killing in a certain time fraction. In clinical treatments,
an interruption can occur from (1) unscheduled DT with machine
failures, (2) increasing the interval between treatment beams through
couch rotations with the non-coplanar beams, and (3) increasing the
interval between multiple beams. Shibamoto et al. evaluated the
dose difference with and without interruptions in in-vivo experi-
ments.3 Cell survival increased by 13% in mammary cell carcinoma,
EMT6, and by 18% in mouse head and neck squamous cell carci-
noma, SCCVII, with a 5-min interval 4,5. The effect on cell survival
with multiple interruptions, such as intensity-modulated radiation
therapy, may be less than those of the same dose without interrup-
tions. Moreover, the effect of cell survival with SLDR appears to
almost plateau after several hours of interruption.6 Brenner et al.
suggested a linear–quadratic (LQ) model with the Lea–Catcheside
time factor to analyze cell survival considering SLDR during irradia-
tion at the cell population level. 7
In this study, the biological effect of the duration of interrup-
tion caused by machine failure was determined using the LQ
model with the Lea–Catcheside time factor of a single interruption
in one fraction, and a risk analysis with SLDR by machine failures
was emphasized. For an institution, the cost associated with
machine DT is a significant factor to consider as the costs associ-
ated with health systems must be economically sustainable.8,9
Hence, machine failure presents a high risk for medical institutions.
The current study proposes a new machine failure risk analysis
(MFRA) method that involves calculating the cost of replacement
of linac parts and the biological effect of DT on patients. Further-
more, the machine failure risk faced by patients and institutions
during treatment for each machine failure was analyzed for two
linacs.
2 | MATERIALS AND METHODS
Two linacs (Clinac iX; Varian Medical Systems, Palo Alto, USA) and
TrueBeam (Varian Medical Systems, Palo Alto, USA) were used for
this study. Clinac iX was introduced in 2009, while TrueBeam was
introduced in 2013.
2.A | Classification of machine failure
Table 1 lists the total number of unplanned intra-fraction machine
failures on a treatment session from April 2015 to April 2018. The
total number of unplanned intra-fraction machine failures was 60.
Based on the 60 failure modes identified, the machine failures were
broadly classified into the following categories: multileaf collimator
(MLC), potentiometer, radio frequency (RF) driver, minor interlock,
water temperature and quantity, monitor chamber and LaserGuard.
The failure associated with the MLC includes failures associated with
the motor, communication, leaf and carriage positioning, and power
supply. If the water temperature increases, low water and gas pres-
sures or other problems cause an interruption during irradiation to
decrease the temperature. Failures associated with the potentiome-
ter and RF driver involve an active interlock, which turns the beam
off during irradiation. These machine failures must be addressed by
replacing the parts. The TrueBeam linac has a collision detection sys-
tem called LaserGuard, which comprises an infrared laser. Laser-
Guard is used to replace the parts when the interlock associated
with the collision cannot be released. The minor interlocks alert the
operator to the existence of conditions that affect machine opera-
tion, such as filament time delay, calibration cycle timeout, and
excess dose rate. This interlock does not require a significant amount
of time to release the interlock, part replacement or a system restart.
It is released by re-mode up, username and password input.
2.B | Machine failure risk analysis
MFRA is performed to calculate the risk faced by patients and insti-
tutions by evaluating the cost of repair and biological effects when
DT occurs. The risk of machine failure during treatment can be
assigned to the following three scores: biological effect, B; occur-
rence, O; and labor and repair part, C. The current study focused on
machine failure, without swapping clinical treatment plans among
beam-matched linacs, and no rescheduling time is available after
treatment of all patients.
2.C | Biological effects in treatment
In this study, we focused on the biological effects of an unplanned
intra-fraction break in a treatment session caused by a machine mal-
function, as shown in Table 1. We assume that, except for this delay,
the total dose for the session was delivered as planned without
swapping with a clinically beam-matched linac and that no
rescheduling time was available for a patient to continue treatment
after the daily treatment of all patients. Moreover, in the current
study, it was assumed that biological effects follow the LQ model,
which provides a simple relationship between cell survival and deliv-
ered dose.10,11 More importantly, the standard LQ formalism, as
applied to time–dose relationships, is not merely a truncated power
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series in dose. The key feature is a specific mechanistically based
functional form for the protraction factor (G), which considers dose
protraction or fractionation. This factor was derived by Lea and
Catcheside.12,13 Brenner et al. applied G to the biological dose calcu-
lation and calculated the survival fraction in the case of two acute
dose fractions,D1 and D2, separated by the DT using the LQ formal-
ism that was incorporated as well as the protraction factor.7 The bio-
logical effect with interruption depends on the DT and dose per
fraction (DPF). In the current study, it was assumed that the inter-
ruption occurred during one-half of the irradiation. The survival frac-
tion with interruption (SFwith) is calculated as follows:
SFwith ¼ exp ðαD1þαD2þβD21þβD22þ2βD1D2eλTÞ
h i
: (1)
Here, λ is the repair rate for double-strand breaks, equal to 2/
T1=2, where T1=2 is the repair half-time. Typical values of α/β are
used for early responding tissues, as listed in Table 2.7 These were
also used in the simulation by Brenner et al.14 The survival fraction
without interruption equivalent to the survival fraction with interrup-
tion is denoted as SFw=o. . The equivalent DPF is defined as DeqDT
when SFwith ¼ SFw=o, as shown in Fig. 1. SFw=o is calculated as fol-
lows:






















Additionally, the biological effect of DT for each DPF is denoted
as BDT,DPF . To calculate BDT,DPF , the maximum DT was used when the
machine failures were classified every 10 min in the range of
0–100 min, as shown in Table 1. For example, when one machine
failure occurred with a DT of 0–10 min, then 10 min was used as
the DT value in the calculation of BDT,DPF . Additionally, a DT exceed-







Occurrence in MFRA is defined as the probability of machine failure
for the DPF of each patient when DT occurs (oDT,DPF,MF). Information
regarding machine failures and DT is shown in Table 1. In practice,
the occurrence is calculated as follows:
oDT,DPF,MF ¼ NDT,DPF,MFtreatmentperiod : (5)
where NDT,DPF,MF is the number of machine failures for the DPF of
each patient when a machine failure with a DT occurs. The evalua-
tion period used was 36 months, which was equivalent to the analy-
sis period.
2.E | Cost of labor and repair parts
The cost of labor is directly related to the payment of the treatment
staff. In the current study, it was assumed that a backup machine
TAB L E 1 Total number of unplanned intra-fraction machine failures and downtime (DT; min).
Machine failure 0 < DT ≤ 10 10 < DT ≤ 20 20 < DT ≤ 30 30 < DT ≤ 40 50 < DT ≤ 60 80 ≤ DT ≤ 90 DT ≥ 100
MLC 4 (3,1) 6 (2,4) 6 (4,2) 0 1 (1,0) 0 2 (1,1)
Potentiometer 4 (0,4) 0 0 1 (1,0) 0 0 1 (1,0)
RF driver 0 0 1 (0,1) 1 (0,1) 0 0 2
Minor interlock 18 (7,11) 0 2 (0,2) 1 0 0 0
Water 2 (2,0) 0 0 3 (3,0) 0 0 1 (1,0)
Cable 0 0 1 (0,1) 0 0 0 1 (0,1)
Monitor chamber 1 (1,0) 0 0 0 0 0 0
LaserGuard 0 0 0 0 0 0 1 (1,0)





F I G . 1 . Correlation between survival fraction and DPF with and
without interruption.
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would not be used. The cost was analyzed based on machine failures
that occurred during an unplanned intra-fraction break in a treat-
ment session, as shown in Table 1. Thus, this study focused on the
labor cost and repair parts for an unplanned intra-fraction break in a
treatment session. The labor cost incurred by two therapists and
nurses in treating a patient when machine failures did not occur was
considered. Meanwhile, various cases pertaining to the labor cost of
an engineer exist. Some hospitals hire engineers or establish a main-
tenance contracts with vendors. Therefore, in the current study, the
labor costs of two therapists and nurses were considered. Moreover,
cost of a physicist was not included in the economic institution risk
(EIR) analysis because flexible working hours are applied to most
physicists and their salary is not paid hourly. The cost of radiother-
apy has been categorized based on high and low-income countries
by Van Dyk et al.15 Using the monthly salary and working time spec-
ified by Van Dyk et al., the total salary of two therapists and nurses
per minute S was calculated as follows:
S¼2 TherapistSalary½ þ1 NurseSalary½ 
workingtime minð Þ : (6)
S was approximately $1.06/min. In addition, the cost of labor for the
event i of machine failure for each DT and DPF clabori was calculated
using.
clabori ¼ S ti: (7)
where ti is the maximum DT when machine failures are divided into
intervals of 10 min in the range of 0–100 min, as shown in Table 1.
For example, when one machine failure occurs with a DT of 0–10 min,
the DT value used in the calculation of clabori is 10 min. Further, a DT
exceeding 100 min was assigned 100 min. The cost of repair using
replacement parts of each machine failure for event i of the machine
failure for each DT and DPF is denoted as cpartsi . Thus, the total cost
including the costs of labor and repair using replacement parts for each
event i of machine failure ctotali is calculated as follows.
ctotali ¼ clabori þcpartsi : (8)
2.F | Biological patient risk (BPR) and economic
institution risk (EIR)
The biological effect of machine failure on patients is defined as the
biological patient risk (BPR) based on the ratio of the number of
patients for each DPF, denoted as BPRDT,DPF,MF . It can be calculated
as follows:
BPRDT,DPF,MF ¼BDT,DPF,MF oDT,DPF,MF (9)
where BPRDT,DPF,MF is the BPRDT,DPF for each machine failure. BPRMF














An example of BPR calculation for water temperature and quan-
tity faults is presented here. This fault occurred three times with DT
of 0–10 min and B¼3:3%, and once with DT of 30–40 min and
B¼5:4% in 2 Gy/fr patients. The calculation is given by:
BPR2Gy=fr ¼3:3 %ð Þ 2 timeð Þ36 monthð Þþ5:4 %ð Þ
1 timeð Þ
36 monthð Þ¼0:33: (12)
Moreover, the water temperature and quantity faults occurred
once with a DT of 30–40 min and B¼8:0%, and twice with a DT
exceeding 100 min and B¼8:2% in 3 Gy/fr patients. This was calcu-
lated as follows:
BPR3Gy=fr ¼8:0 %ð Þ 2 timeð Þ36 monthð Þþ8:2 %ð Þ
1 timeð Þ
36 monthð Þ¼0:67: (13)
For the other DPF, the faults of water temperature and quantity
did not occur. The total BPRMF with 2–20 Gy for these faults is cal-
culated using:
BPRMF ¼0:33þ0:67¼1:00: (14)
2.G | Sensitivity of BPR
Leeuwen et al. reported large variations in their published values for
the LQ parameters α/β between different tumor types.16 Addition-
ally, they reported that variations appeared in a study of the same
tumor type. This is known as study heterogeneity, which occurs in
studies where a value is estimated that is only valid for a specific
method and the patient cohort of that particular study. Hence, the
sensitivity of the BPR was investigated for variations of α/β and T1=2,
which are the parameters of the LQ model with the Lea-Catcheside
time factor, respectively. The α/β was 2 Gy for typical late-respond-
ing normal tissues and 10 Gy for typical early-responding normal tis-
sues and tumors. In addition to the typical values for early-
responding tissues shown by Brenner et al.,7 T1=2 was 0.2 and 0.5 hr.
2.H | Sensitivity of EIR
The sensitivity of EIRMF to the variation in labor cost was investi-
gated. The labor cost was eliminated by assuming that a backup
machine can be used, and that all patients with machine failures can
be transferred to the backup machine without overtime. The EIR for
each machine failure without a backup machine is defined by Eq. 12.
The EIR for each machine failure with a backup machine (EIRBAMF ) is
defined as the ratio of the cost of repair parts to the total cost:






3.A | Biological effects with downtime
Figure 2 shows the BDT,DPF vs. DTs of 0–100 min for the doses—2,
3, 5, 10, and 20 Gy with the cell parameters shown in Table 2. B
increased with higher doses and longer DT. In particular, the rate of
increase of BDT,DPF until the DT of 40 min was higher for increased
doses.
3.B | BPR and EIR for both linear accelerators
Figures 3 and 4 show the BPRMF and EIRMF with both linacs. The
MLC fault had the highest BPRMF and the second highest EIRMF.
The EIRMF for the LaserGuard fault was the highest. Meanwhile, the
minor interlock had the second highest BPRMF, whereas it had the
smallest EIRMF. The EIRMF for the monitor chamber fault was the
second highest, while the BPRMF was the smallest. Additionally, the
BPRMF and EIRM for the water temperature and quantity faults were
higher and smaller, respectively than those of machine failures
caused by the potentiometer, RF driver and cable.
3.C | BPRMF and EIRMF for each machine
Figures 5 and 6 show the BPRMF and EIRMF in both TrueBeam and
Clinac iX. TrueBeam had the highest BPRMF for MLC failures,
whereas, Clinac iX had the highest BPRMF for minor interlock failure.
The total EIRMF in TrueBeam was significantly higher than that in
Clinac iX. The EIRMF was the highest for the LaserGuard fault in
TrueBeam. Although Clinac iX had the highest EIRMF for MLC fail-
ures, the value was smaller than that of TrueBeam. The BPRMF from
a minor interlock fault, F was the second highest; whereas, its EIRMF
was smaller for both linacs. Although the BPRMF for RF driver failure
in TrueBeam was larger than that in Clinac iX, the EIRMF for RF dri-
ver failure in Clinac iX was larger than that in TrueBeam. Although
the minor interlock fault in Clinac iX had a higher BPRMF, it had a
smaller EIRMF in TrueBeam.
3.D | Sensitivity analysis of BPRMF
Figure 7 shows the variations in BPRMF for the machine failures
caused by the MLC, potentiometer, RF driver, minor interlock, water
temperature and quantity, cable, monitor chamber and LaserGuard.
The BPRMF decreased with higher T1=2 and α/β values.
3.E | Sensitivity of EIR
Figure 8 shows the variations in EIRMF for the machine failures
caused by the MLC, potentiometer, RF driver, minor interlock, water
temperature and quantity, cable, monitor chamber and LaserGuard
with and without a backup machine. The EIRMF for the MLC, poten-
tiometer, and RF driver faults decreased slightly when the backup
machine was used. In particular, the EIRMF for the water tempera-
ture and quantity faults reduced by more than one half when the
backup machine was used. Meanwhile, the EIRMF values of the
cable, monitor chamber, and LaserGuard with and without a backup
machine almost did not differ.
4 | DISCUSSION
The BDT,DPF increased with higher DPF and DT, as shown in Fig. 2.
In clinical practice, the treatment technique and DPF differ for each
patient. The difference between the DT and DPF is considered in
the BPR for machine failures. In this study, the effects of multiple
treatments on BPR were not considered. We would expect the BPR
to be reduced for multi-fraction treatments as opposed to single-
fraction treatments. The current study focused on machine failure
with a high BPR. Although the DT caused by the minor interlock is
not very long, the highest BPR would depend on the probability of
occurrence of the minor interlock fault. The total BPR for the MLC
was the highest, and it was significantly higher in TrueBeam. The
time elapsed since linac installation may affect the number of
machine failures. Therefore, the BPR should be evaluated for each
linac. Wroe et al. analyzed machine failures in the UK, Nigeria, and
F I G . 2 . BDT,DPF with a downtime of
0–100 min at doses of 2–20 Gy with cell
parameters shown in Table 2 (α = 0.12 Gy-
1, β = 0.0137 Gy-1, and T1/2 = 0.35).
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Botswana.17 They reported that the number of machine failures in
MLCs was larger immediately after a linac is introduced. Machine
failures 3–6 a after the introduction of TrueBeam and 7–10 a after
the introduction of Clinac iX were analyzed. It was discovered that
the frequency of machine failures was larger in TrueBeam. However,
the sample size was small for both linacs; thus, more data need to
be collected. From the sensitivity analysis of the BPR, for smaller α/β
values, the BPR increases. The parameters differed for each tumor
or normal tissue type. Moreover, in the LQ model, the effects of sin-
gle high doses may be difficult to predict. The limitation of the cur-
rent study is the lack of consensus regarding radiobiological
formalism and cell parameters for different tumor and normal tis-
sues. In the current study, the formalism and cell parameters were
assumed to be fully validated, and a new framework for BPR calcula-
tion was suggested. Several models have been proposed for
hypofractionation therapy schemes, such as the modified linear–-
quadratic, linear–quadratic–linear, and generalized linear–quadratic
models.18–20 These biological models and various LQ parameters are
applicable to the BPR model using the procedure developed in this
study.
In addition to BPR, an EIR analysis was conducted to estimate
the risk of economic cost in a medical institution. As shown by the
results in Figs. 3 and 4, the patient and economic cost risks differ.
Although the BPR for the minor interlock fault was the highest in
Clinac iX and second highest in TrueBeam, the EIR effect was the
least prominent. This interlock fault did not require part exchange,
F I G . 3 . BPRMF for machine failures
caused by MLC, potentiometer, RF driver,
minor interlock, water temperature and
quantity, cable, monitor chamber, and laser
guard in TrueBeam and Clinac iX.
F I G . 4 . EIRMF for machine failures
caused by MLC, potentiometer, RF driver,
minor interlock, water temperature and
quantity, cable, monitor chamber, and laser
guard in TrueBeam and Clinac iX.
F I G . 5 . BPRMF for machine failures
caused by MLC, potentiometer, RF driver,
minor interlock, water temperature and
quantity, cable, monitor chamber, and
LaserGuard in TrueBeam and Clinac iX.
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although the risk of biological effect was higher for the patient.
Hence, the BPR may be reduced by confirming the alert and per-
forming fault handling rapidly without considering the cost. The
water temperature and quantity faults indicated BPRs and the small-
est EIR in both linacs. A fault with a higher BPR and smaller EIR may
exhibit the highest risk reduction impact if the user contacts an engi-
neer immediately because the costs of labor and repair parts are
low. Meanwhile, the EIR was higher for the monitor chamber and
LaserGuard, though not of high frequencies and occurred only in
TrueBeam. Our study showed that variations occurred in the DT
ratio, cost of labor, and repair parts across machine types. These
results are supported by a preceding study.21 Dufek et al. analyzed
the DT of linacs at 13 institutions.21 They discovered variations in
DT percentages across the institutions. Machine failures may depend
on the introduction time of a machine or on an individual machine.
Specifically, the EIR depends on the occurrence probability of
F I G . 6 . EIRMF for machine failures
caused by MLC, potentiometer, RF driver,
minor interlock, water temperature and
quantity, cable, monitor chamber, and
LaserGuard in TrueBeam and Clinac iX.
F I G . 7 . BPRMF for machine failures
caused by MLC, potentiometer, RF driver,
minor interlock, water temperature and
quantity, cable, monitor chamber, and
LaserGuard in TrueBeam and Clinac iX
with (a) T1=2 of 0.2–0.5 and α/β of 10 Gy,
and (b) T1=2 of 0.35 and α/β of 2–10 Gy.
F I G . 8 . EIRMF for machine failures
caused by MLC, potentiometer, RF driver,
minor interlock, water temperature and
quantity, cable, monitor chamber, and
LaserGuard with and without backup
machine.
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machine failures and the costs of labor and repair parts, which vary
according to machine type or vendor. Moreover, the tolerances of
the machine fault differ for the two machines. Older machines may
allow an operation with looser machine tolerances before a fault
occurs. For example, unlike Clinac iX, TrueBeam has a collision inter-
lock by LaserGuard. This might increase the risk for TrueBeam,
which is a newer machine. From this discussion, it is clear that the
machine failure risk faced by patients and institutions depends on
many factors. Therefore, the manner in which failures occur in each
institution must be understood such that a maintenance contract can
be generated according to the risk level and the appropriate method
of machine failure management can be determined.
Although scheduled preventative maintenance was performed in
our institution by engineers, the interval of preventative mainte-
nance was several months, which is insufficient. The preemptive
maintenance model by the institution staff introduced in the previ-
ous study may resolve this problem.22 Able et al. attempted to cre-
ate a model for the preemptive maintenance of medical linacs during
MLC faults.22 They created a system that automatically and swiftly
transferred log files and provided alerts regarding accumulation in
the accelerator system.22 This system can improve the efficient
deployment of service engineering resources, thereby resulting in
fewer interruptions to treatment. Hence, preventive maintenance or
remote support can reduce the DT, and the labor cost and biological
effect can be reduced for planned after-hours maintenance rather
than for unscheduled maintenance.
Additionally, a backup linac can be used to reduce the risk if one
is available during a machine failure. Xu et al. compared the passing
rates of film measurement, ArcCHECK, and point doses for a clinical
treatment plan among beam-matched linacs.23 They demonstrated
the availability of a swapping clinical plans among beam-matched
linacs. These back-up systems can improve the throughput and
reduce the BPR and EIR from machine problems. The sensitivity
analysis of the EIR shows that using a backup machine can reduce
the EIR. However, treatment with a backup machine poses another
risk. Thus, a swift patient quality assurance for each treatment plan
and a plan verification for the remaining MU and segment after a
machine breaks down is necessary. Determination of the action level
or threshold for the biological and economic risks by the machine
faults is outside the scope of the current study. Biological and eco-
nomic risks were independent. Therefore, the action level depends
on the institution because the risk priority differs for each institu-
tion. The MFRA can be used to control and evaluate patient risk or
economic risk. In future studies, the MFRA system will be expanded
simulate risk reduction by performing MFRA after applying the risk-
reducing methods presented herein.
5 | CONCLUSIONS
In machine failure, the risks faced by patients and institutions differ.
The proposed MFRA contributes to the reduction in economic cost
for institutions and biological effects on patients. Furthermore, the
risk effects on patients and institutions differed between TrueBeam
and Clinac iX. Identifying the machine failure risk faced by patients
and institutions during treatment is critical for each institution and
can offer prevention through model creation for preemptive mainte-
nance to mitigate the risk, or through feedback to service engineer-
ing.
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